BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16413018)

  • 1. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
    Yu DH; Fan W; Liu G; Nguy V; Chatterton JE; Long S; Ke N; Meyhack B; Bruengger A; Brachat A; Wong-Staal F; Li QX
    Exp Cell Res; 2006 Apr; 312(6):865-76. PubMed ID: 16413018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis.
    Ke N; Claassen G; Yu DH; Albers A; Fan W; Tan P; Grifman M; Hu X; Defife K; Nguy V; Meyhack B; Brachat A; Wong-Staal F; Li QX
    Cancer Res; 2004 Nov; 64(22):8208-12. PubMed ID: 15548686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line.
    Jahn JE; Coleman WB
    Int J Oncol; 2008 Feb; 32(2):441-9. PubMed ID: 18202767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
    Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
    Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway.
    Tanikawa C; Furukawa Y; Yoshida N; Arakawa H; Nakamura Y; Matsuda K
    Oncogene; 2009 Aug; 28(34):3081-92. PubMed ID: 19543321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
    Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
    Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
    Ford J; Jiang M; Milner J
    Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1.
    Yoo YA; Kim MJ; Park JK; Chung YM; Lee JH; Chi SG; Kim JS; Yoo YD
    Mol Cell Biol; 2005 Aug; 25(15):6603-16. PubMed ID: 16024796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway.
    Park WR; Nakamura Y
    Cancer Res; 2005 Feb; 65(4):1197-206. PubMed ID: 15735003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
    Tanaka T; Ohkubo S; Tatsuno I; Prives C
    Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
    Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
    Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 3 activates p53-dependent cell growth inhibition.
    Kim TK; Lee JS; Jung JE; Oh SY; Kwak S; Jin X; Lee SY; Lee JB; Chung YG; Choi YK; You S; Kim H
    Cancer Lett; 2006 Oct; 242(2):215-21. PubMed ID: 16513254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell.
    O'Connor JC; Wallace DM; O'Brien CJ; Cotter TG
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4237-44. PubMed ID: 18487368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.